591: The Obstetric and Neonatal Outcomes of Inflammatory Bowel Disease in Pregnancy and Associated Medication Use

American Journal of Obstetrics and Gynecology - United States
doi 10.1016/j.ajog.2018.11.613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pregnancy Outcomes of Women With Inflammatory Bowel Disease

Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor
2013English

Vedolizumab Exposure in Pregnancy: Outcomes From Clinical Studies in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons

Middle East Journal of Digestive Diseases
HepatologyGastroenterology
2016English

Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab

Gastroenterologie a Hepatologie
HepatologyGastroenterology
2018English

Alcohol and Narcotics Use in Inflammatory Bowel Disease

Annals of Gastroenterology
2018English

Insights Into the Treatment of Inflammatory Bowel Disease in Pregnancy

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

In Utero Exposure to Antihypertensive Medication During Pregnancy and Neonatal and Child Health Outcomes

International Journal of Population Data Science
2017English

The Effects of Pregnancy on the Pharmacokinetics of Infliximab and Adalimumab in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Long-Term Outcomes and Disease Burden of Neonatal Onset Short Bowel Syndrome

Journal of Pediatric Surgery
MedicineChild HealthSurgeryPediatricsPerinatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy